The future of alternating therapies looks promising, with ongoing research focused on optimizing treatment combinations and sequences. Advances in personalized medicine and genomics are expected to play a significant role in tailoring alternating therapies to individual patients. Additionally, the integration of artificial intelligence and machine learning in treatment planning could enhance the precision and effectiveness of these therapies.
